The fund was located in Europe if to be more exact in Belgium. The main department of described VC is located in the Bel.
Among the most popular portfolio startups of the fund, we may highlight Plastic Logic Germany, F2G, Flayr. The fund has specific favorite in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical.
The top activity for fund was in 2014. The increased amount of exits for fund were in 2007. This Merifin Capital works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Besides them, we counted 5 critical employees of this fund in our database.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Merifin Capital, startups are often financed by Principia SGR, Astellas Venture Management, Amadeus Capital Partners. The meaningful sponsors for the fund in investment in the same round are 360 Capital Partners, Sunstone Life Science Ventures, Quest for Growth. In the next rounds fund is usually obtained by Wellington Partners, 360 Capital Partners, dievini Hopp Biotech Holding.
Related Funds
Funds with similar focus
Fund Name | Location |
ADC Telecommunications | Eden Prairie, Minnesota, United States |
Breton Capital Management | Boston, Massachusetts, United States |
FTSE 100 Listed Healthcare Company | - |
GLG | New York, New York, United States |
Pingtan Dongfeng Jiankang Yiliao Touzi | China, Fujian, Pingtan |
Sijia Jianxin Fund | - |
Sparkland Capital | California, San Jose, United States |
TCF Capital Funding | - |
Teo Hong Silom | Samut Prakan, Samut Prakan Province, Thailand |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
DoveConviene | $11M | 25 Sep 2015 | Sardinia | ||
DoveConviene | $6M | 03 Dec 2014 | Sardinia | ||
Flayr | $6M | 20 Nov 2013 | Ile-de-France | ||
DanioLabs | $4M | 17 Jan 2005 | England | ||
immatics biotechnologies | $9M | 11 Feb 2004 | Baden-Württemberg | ||
Optiva | $21M | 10 Jan 2003 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
DoveConviene | $11M | 25 Sep 2015 | Sardinia | ||
DoveConviene | $6M | 03 Dec 2014 | Sardinia | ||
Flayr | $6M | 20 Nov 2013 | Ile-de-France | ||
DanioLabs | $4M | 17 Jan 2005 | England | ||
immatics biotechnologies | $9M | 11 Feb 2004 | Baden-Württemberg | ||
Optiva | $21M | 10 Jan 2003 | San Francisco, California, United States |